Search / 319 results found

from
to

MONDAY, May 16, 2022 (HealthDay News) -- During omicron predominance, the estimated vaccine effectiveness (VE) of the BNT162b2 two-dose vaccination among children and adolescents was modest and decreased rapidly, according to a study published online May 13 in the Journal of the American Medical Association.

TUESDAY, May 10, 2022 (HealthDay News) -- Evidence of quality control problems was hidden by a company contracted by the U.S. government to produce hundreds of millions of COVID-19 vaccine doses, a new House committee report shows.

  • Updated

FRIDAY, May 6, 2022 (HealthDay News) -- Citing the accumulated data on a raised risk for thrombosis with thrombocytopenia syndrome (TTS), the U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson & Johnson COVID-19 vaccine.

THURSDAY, May 5, 2022 (HealthDay News) -- Citing the accumulated data on a raised risk for a type of dangerous blood clot, the U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson & Johnson COVID-19 vaccine.

  • Updated

MONDAY, May 2, 2022 (HealthDay News) -- Among patients with Lennox-Gastaut syndrome (LGS), the percentage reduction in the frequency of drop seizures is greater with fenfluramine versus placebo, according to a study published online May 2 in JAMA Neurology.

  • Updated

THURSDAY, March 3, 2022 (HealthDay News) -- For adolescents, BNT162b2 vaccine effectiveness (VE) was lower against COVID-19-associated emergency department and urgent care encounters during omicron predominance, according to research published in the March 1 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

  • Updated

THURSDAY, March 3, 2022 (HealthDay News) -- There is a dose-response relationship between years of ice hockey play and chronic traumatic encephalopathy (CTE) risk and severity, according to a study scheduled for presentation at the upcoming annual meeting of the American Academy of Neurology, to be held from April 2 to 7 in Seattle.